Pages that link to "Q40226195"

The following pages link to Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene (Q40226195):

Displaying 25 items.

• T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance (Q26747638) (← links)
• New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity (Q26800976) (← links)
• Idiosyncratic adverse drug reactions: current concepts (Q26824391) (← links)
• Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients (Q33590419) (← links)
• Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming (Q33632910) (← links)
• Alleviation of skin inflammation after Lin(-) cell transplantation correlates with their differentiation into myeloid-derived suppressor cells (Q36123802) (← links)
• The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans (Q36940046) (← links)
• Quantifying human susceptibility to contact sensitization; risk assessments now and in the future (Q37800160) (← links)
• Contact hypersensitivity: quantitative aspects, susceptibility and risk factors (Q38161479) (← links)
• Nutritional abrogation of photoimmunosuppression: in vivo investigations (Q38166784) (← links)
• Immunomodulation of malignant melanoma by contact sensitizing agents (Q38168949) (← links)
• The lymphocyte transformation test in allergic contact dermatitis: New opportunities (Q38345368) (← links)
• Effects of Hovenia dulcis Thunb. extract and methyl vanillate on atopic dermatitis-like skin lesions and TNF-α/IFN-γ-induced chemokines production in HaCaT cells (Q38739924) (← links)
• Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas (Q38887303) (← links)
• Systemic drugs inducing non-immediate cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells. (Q38968812) (← links)
• Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein (Q43285197) (← links)
• Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in p-phenylenediamine allergic patients and tolerant individuals (Q43298049) (← links)
• Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice. (Q45764606) (← links)
• Contact sensitizers trigger human CD1-autoreactive T-cell responses (Q48235811) (← links)
• In vitro human T cell responses to diphencyprone. (Q50790144) (← links)
• Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis (Q50907995) (← links)
• CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells. (Q50964324) (← links)
• T lymphocyte dynamics in methylisothiazolinone-allergic patients. (Q54454334) (← links)
• Nature and kinetics of redox imbalance triggered by respiratory and skin chemical sensitizers on the human monocytic cell line THP-1. (Q55345001) (← links)
• In vitrodiagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions (Q58039375) (← links)